Topics
Diffuse midline glioma | Treatment | Targeted therapy | Omburtamab
Home > Publications > Topics > Diffuse midline glioma > Treatment > Targeted therapy > Omburtamab
Souweidane MM, Bander ED, Zanzonico P, Reiner AS, Manino N, Haque
S, Carrasquillo JA, Lyashchenko SK, Thakur SB, Lewis JS, Donzelli
M, Cheung NV, Larson SM, Kramer K, Pandit-Taskar N, Dunkel IJ.
Phase 1 dose-escalation trial
using convection-enhanced delivery
(CED) of radio-immunotheranostic
124I-Omburtamab for diffuse intrinsic
pontine glioma (DIPG).
Neuro
Oncol. 2025 Feb 19:noaf039. doi:
10.1093/neuonc/noaf039. PMID:
39969230. Interventional study˰
ˍ